CY1113061T1 - Ανοσογονες συνθεσεις για θεραπεια και προληψη ζωικων μολυνσεων - Google Patents
Ανοσογονες συνθεσεις για θεραπεια και προληψη ζωικων μολυνσεωνInfo
- Publication number
- CY1113061T1 CY1113061T1 CY20121100757T CY121100757T CY1113061T1 CY 1113061 T1 CY1113061 T1 CY 1113061T1 CY 20121100757 T CY20121100757 T CY 20121100757T CY 121100757 T CY121100757 T CY 121100757T CY 1113061 T1 CY1113061 T1 CY 1113061T1
- Authority
- CY
- Cyprus
- Prior art keywords
- leptospira
- canine
- compositions
- prevention
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Η παρούσα αποκάλυψη αναφέρεται σε πολυσθενείς ανοσογόνους συνθέσεις για θεραπεία ή πρόληψη ασθενειών ή διαταραχών σε κυνοειδή που προκαλούνται ή συνδέονται με έναν ή περισσότερους από τους ιό κυνοειδούς λοιμού, κυνοειδή αδενοϊό (τύπου 1 ή τύπου 2), ιό κυνοειδούς παραγρίπης, κυνοειδή παρβοϊό, Leptospira canicola, Leptospira icterohaemorrhagiae, Leptospira grippotyphosa, Leptospita pomona, Leptospira bratislava, Leptospira hardjo, Leptospira autumnalis, Leptospira australis, Leptospira hebdomadis, και Bordetella bronchiseptica. Οι Leptosira συνθέσεις μπορούν επίσης να χρησιμοποιηθούν για θεραπεία ή πρόληψη ασθενειών ή διαταραχών σε κυνοεδή, χοιροειδή και βοοειδή.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90358607P | 2007-02-27 | 2007-02-27 | |
| EP08730629A EP2134742B1 (en) | 2007-02-27 | 2008-02-25 | Immunogenic compositions for treating and preventing animal infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113061T1 true CY1113061T1 (el) | 2016-04-13 |
Family
ID=39714016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121100757T CY1113061T1 (el) | 2007-02-27 | 2012-08-23 | Ανοσογονες συνθεσεις για θεραπεια και προληψη ζωικων μολυνσεων |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100233204A1 (el) |
| EP (1) | EP2134742B1 (el) |
| JP (1) | JP5470052B2 (el) |
| AU (1) | AU2008219380B2 (el) |
| CY (1) | CY1113061T1 (el) |
| DK (1) | DK2134742T3 (el) |
| ES (1) | ES2389121T3 (el) |
| PL (1) | PL2134742T3 (el) |
| PT (1) | PT2134742E (el) |
| SI (1) | SI2134742T1 (el) |
| WO (1) | WO2008106393A2 (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2224951T3 (da) * | 2007-12-21 | 2020-01-06 | Zoetis Services Llc | Varmebehandlede bakteriner og emulsionsvacciner, der er fremstillet af sådanne varmebehandlede bakteriner |
| CN109735504B (zh) * | 2018-12-20 | 2021-04-16 | 兆丰华生物科技(南京)有限公司 | 犬瘟热病毒弱毒疫苗株及其应用 |
| AU2021254768A1 (en) * | 2020-04-14 | 2022-11-17 | The Regents Of The University Of California | Large sequence pan-Coronavirus vaccine compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658757A (en) * | 1993-03-31 | 1997-08-19 | The Regents Of The University Of California | Cloned leptospira outer membrane protein |
| EP2447278B1 (en) * | 2002-10-10 | 2015-04-08 | Cornell Research Foundation, Inc. | Novel immunogenic proteins of Leptospira |
| US20050089533A1 (en) | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| JP2006515024A (ja) * | 2003-01-29 | 2006-05-18 | ファイザー・プロダクツ・インク | Ｂｏｒｄｅｔｅｌｌａｂｒｏｎｃｈｉｓｅｐｔｉｃａに対するイヌワクチン |
-
2008
- 2008-02-25 PL PL08730629T patent/PL2134742T3/pl unknown
- 2008-02-25 ES ES08730629T patent/ES2389121T3/es active Active
- 2008-02-25 SI SI200830704T patent/SI2134742T1/sl unknown
- 2008-02-25 AU AU2008219380A patent/AU2008219380B2/en active Active
- 2008-02-25 WO PCT/US2008/054867 patent/WO2008106393A2/en active Application Filing
- 2008-02-25 DK DK08730629.6T patent/DK2134742T3/da active
- 2008-02-25 EP EP08730629A patent/EP2134742B1/en active Active
- 2008-02-25 JP JP2009551796A patent/JP5470052B2/ja active Active
- 2008-02-25 PT PT08730629T patent/PT2134742E/pt unknown
- 2008-02-25 US US12/528,822 patent/US20100233204A1/en not_active Abandoned
-
2012
- 2012-08-23 CY CY20121100757T patent/CY1113061T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100233204A1 (en) | 2010-09-16 |
| WO2008106393A3 (en) | 2008-12-04 |
| DK2134742T3 (da) | 2012-08-06 |
| EP2134742A2 (en) | 2009-12-23 |
| PT2134742E (pt) | 2012-09-06 |
| AU2008219380B2 (en) | 2014-01-30 |
| ES2389121T3 (es) | 2012-10-23 |
| PL2134742T3 (pl) | 2012-10-31 |
| SI2134742T1 (sl) | 2012-09-28 |
| EP2134742B1 (en) | 2012-06-27 |
| WO2008106393A2 (en) | 2008-09-04 |
| AU2008219380A1 (en) | 2008-09-04 |
| JP2010518875A (ja) | 2010-06-03 |
| JP5470052B2 (ja) | 2014-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR064530A1 (es) | Procedimientos para la administracion de vacunas | |
| ME01156B (me) | Postupci i kompozicije za imunizaciju svinja protiv svinjskog cirkovirusa | |
| JP2015526450A5 (el) | ||
| LU92136I2 (fr) | Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava | |
| BR112012023046A2 (pt) | vacinas de vírus de febre aftosa recombinantes e seus respectivos usos | |
| MX2011006846A (es) | Virus de fiebre porcina clasico recombinante (csfv) comprendiendo una proteina e2 modificada y metodos para generar dicho csfv. | |
| ECSP11010975A (es) | Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales | |
| HRP20090271A2 (en) | Vaccine for respiratory and reproductive system infections in cattle | |
| DE602006015665D1 (de) | Probiotische enterokokken für eine verbesserte immunität | |
| CY1113599T1 (el) | Μειωση συνακολουθων μολυνσεων σε χοιρους με τη χρηση του pcv2 αντιγονου | |
| PE20110023A1 (es) | Composiciones inmunogenicas de antigenos de staphylococcus aureus | |
| PE20030285A1 (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
| BR112019009133A2 (pt) | vacina contra o parvovírus suíno | |
| AR043892A1 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
| MX2009006178A (es) | Vacuna contra salmonela. | |
| CY1113061T1 (el) | Ανοσογονες συνθεσεις για θεραπεια και προληψη ζωικων μολυνσεων | |
| ME01140B (me) | Virus goveđe virusne dijareje s modifikovanim erns proteinom | |
| AR042935A1 (es) | Vacunas caninas contra bordetella bronchiseptica | |
| NZ591950A (en) | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition | |
| ATE473236T1 (de) | Antigene von piscirickettsia salmonis und deren verwendung | |
| BRPI0417167A (pt) | composições para animais de estimação compreendendo oligofrutose de cadeia curta | |
| RU2009120894A (ru) | Вакцина против лаймской болезни собак | |
| BR112021020777A2 (pt) | Vacina de subunidade do csfv | |
| MX2020008913A (es) | Metodo para reducir el escatol y/o indol en animales. | |
| BRPI0607473A2 (pt) | infecção por helicobacter em suìnos |